JSB_LOGO
  • Home
  • About Us
  • Categories
  • Blog
  • News
  • Entertainment
  • Sports
  • Contact Us
Login Register 0
  • Home
  • News
  • Government Could Ban Online Pharmacy Apps Like MediBuddy, NetMeds, Tata 1mg, and Others
Government Could Ban Online Pharmacy Apps Like MediBuddy, NetMeds, Tata 1mg, and Others

Government Could Ban Online Pharmacy Apps Like MediBuddy, NetMeds, Tata 1mg, and Others

E-pharmacies may undergo a ban or stricter regulation from the government because of violation of medicine regarding privacy, data, and the sale of drugs.
Written by: Arjita Gupta
Edited by: Krutarth Ghosalkar
Last Updated: March 16, 2023

E-pharmacy apps such as NetMeds, Tata 1mg, and others may soon face a ban over the sale of online medicine for violating the norms of the government. The Union Health Ministry in India is planning to take strict action against online drug stores that sell medications. This is because of increased concerns over malpractices, security concerns over privacy and data, as well as the baseless sale of medicines. A close source revealed that the government may propose a complete ban.

The revised draft of the New Drugs, Medical Devices and Cosmetics Bill, 2023 is presently going through inter-ministerial consultation. And as per the proposal of the Central Government, it may prohibit or restrict, regular the same and distribution of any medication sold online or at e-pharmacies. The bill is intended as a replacement for the existing Drugs and Cosmetics Act of 1940. And the renewed draft disables the provision earlier listed in the old draft bill. Here permission was required to operate e-pharmacies.

In the old draft, it was noted that no person could sell, exhibit, offer for sale, stock, or distribute by himself on done by any other person on his behalf of him through e-pharmacy (online medical store) except under and in accordance with permission or license. The government wishes to have better control over the functioning of online pharmacies. It wants to set improved regulations and get rid of the irrational use of prescription medicines, as well as maintain the security and privacy of patient data.

Most online pharmacy apps collect data related to the region and area-wise details, medicine consumption, and others. And this increases the risk to the safety of the patient. Support to ban online pharmacies has found support from a group of ministers already. The proposed regulations are to ensure the safety and efficacy of medicines and growing concerns about them being sold in online pharmacies, which are otherwise not under proper regulatory mechanisms.

The decision to ban or regulate e-pharmacies is in regard to tensions about the security and privacy of patient data. The misuse of data is thus, the point of contention here. Some of the pharmacy apps, which are quite popular and may come under purview are Amazon, MediBuddy, Apollo, Tata 1mg, Flipkart, Practo, and NetMeds. They have already received show-cause notices from DCGI (Drugs Controller General of India) in February for violating norms over the online sale of medicines.

The DCGI order was sent to all Union Territories and States in November and May 2019, and then again on 3 February 2023, confirming them to comply with the norms of the government.

Recent Post

...
Maruti Suzuki Fronx, MG Comet, Lamborghini Urus S And Other Cars Will Be Launched in April 2023
March 25, 2023
...
Short-Term Capital Gains to Apply on Mutual Funds from 1 April 2023, Know the Details
March 24, 2023
...
Firefly the AI-based Model by Adobe Can Perform Hi-tech Functions
March 23, 2023
...
Microsoft to Develop Mobile Gaming App Store for Smartphones by Early 2024
March 21, 2023
...
Japan PM Fumio Kishida Visits India on 20 March for Two Days to Discuss Bilateral Ties
March 20, 2023
About Us
A Closer View Of The Market

As our tagline suggests, JSB Market Research is a company that offers comprehensive and insightful market research reports helping you to get a closer view of the market.

Our research team has in-house specialists who track the latest News and Entertainment updates occurring in India and abroad and informs the audience with easy-to-understand news pieces. The content strategist and digital marketing department work in tandem to create palpable video materials and actively share them across our official social media channels. We also intensively check out the market scenarios to bring ahead scrutinized blog posts completed with facts and opinions. With ingrained expertise, we are destined to constantly learn, innovate, and share knowledge with everyone.


Company Links
  • Terms & Conditions
  • Disclaimers
  • How To Order
  • Policies
  • Blog
  • News
  • Categories

Follow Us
facebook twitter youtube
instagram linkedin pinterest
Google News
Follow Us

Address
NMS Titanium, Office No. - 807, 8th floor, Plot no .74,Sector 15, Navi Mumbai – 400614, MH- INDIA
contact@jsbmarketresearch.com
+ 91 7710006748
Copyright © JSB Market Research Pvt Ltd 2013 - 2023 All Rights Reserved.
  • Pharmaceuticals
  • Consumer Goods
  • Energy and Utilities
  • Finance and Banking
  • Food and Beverages
  • Defense
  • Healthcare and Medical
  • Technology
  • Leisure
  • Logistics
  • Advertising and Media
  • Paper and Packaging
  • Publishing and Printing
  • Retail
  • Security
  • Telecommunications
  • Textiles and Clothing
  • Travel and Tourism
  • Construction
  • Chemicals
  • Business Services
  • Automotive and Parts
  • Agriculture
  • Materials
  • Aerospace
  • Personal Care
  • Education
  • Company Profile
  • Electronics
  • SWOT Analysis
  • Industrial